Lupus & antiphospholipid syndrome

Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations

J RheumatolPublished Qualitative descriptive study

Authors' conclusion

Overall, this study underscores the significance of optimizing both the information content and determining the appropriate delivery of the tool for its future sustainability.

Study context

Population
Patients with systemic lupus erythematosus (SLE) who viewed an SLE decision aid implemented in 15 rheumatology clinics throughout the United States, May to July 2022
Participants
24 patients
Outcome
Patient experiences with the SLE decision aid
Methodological detailssemistructured interviews, convenience sample
  • Semistructured interviews
  • Convenience sample

Main finding

As reported in the abstract

  • Patients recognized the value of the SLE decision aid (DA) in providing general knowledge about SLE and treatment options
  • Patients desired more comprehensive lifestyle information to better manage their condition
  • Importance of multiple formats to cater to different needs, and of tailoring the DA to different stages of SLE

Original publication

Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations. J Rheumatol. Published 15 May 2024. doi:10.3899/jrheum.2023-1178

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.